HUTCHMED (China) Limited - American Depositary Shares (HCM) earnings
Quarterly and annual HCM reports and results, each read against the price at its own news timestamp. Back to the HCM overview →
3 measured HCM earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| HUTCHMED Reports 2025 Full Year Results and Business Updates | Press release | +0.51% | +1.09% | |
| HUTCHMED Reports 2024 Full Year Results and Provides Business Updates | Press release | +1.64% | +4.93% | |
| HUTCHMED Reports 2023 Full Year Results and Provides Business Updates | Press release | +1.00% | -4.58% |
Keep exploring
More HCM: analyst actions → · SEC filings → · HCM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MiMedx Group, Inc (MDXG) | 265 | +0.14% | 57% |
| Relmada Therapeutics, Inc. (RLMD) | 265 | -0.01% | 44% |
| iBio, Inc. (IBIO) | 263 | -0.38% | 43% |
| NOVUS THERAPEUTICS (NVUS) | 263 | -0.14% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.